These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31509111)

  • 1. Erratum: Cell penetrating peptide-modified nanoparticles for tumor targeted imaging and synergistic effect of sonodynamic/HIFU therapy [Corrigendum].
    Int J Nanomedicine; 2019; 14():6867. PubMed ID: 31509111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell penetrating peptide-modified nanoparticles for tumor targeted imaging and synergistic effect of sonodynamic/HIFU therapy.
    Li Y; Hao L; Liu F; Yin L; Yan S; Zhao H; Ding X; Guo Y; Cao Y; Li P; Wang Z; Ran H; Sun Y
    Int J Nanomedicine; 2019; 14():5875-5894. PubMed ID: 31534329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erratum: Synthesis and Study of Cell-Penetrating Peptide-Modified Gold Nanoparticles [Corrigendum].
    Int J Nanomedicine; 2021; 16():4177-4178. PubMed ID: 34168447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erratum: Phase-Shift, Targeted Nanoparticles for Ultrasound Molecular Imaging by Low Intensity Focused Ultrasound Irradiation [Corrigendum].
    Int J Nanomedicine; 2020; 15():6325. PubMed ID: 32943864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erratum: Quantification of Synergistic Effects of Ceragenin CSA-131 Combined with Iron Oxide Magnetic Nanoparticles Against Cancer Cells [Corrigendum].
    Int J Nanomedicine; 2023; 18():659-662. PubMed ID: 36798533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erratum: Construction of High Loading Natural Active Substances Nanoplatform and Application in Synergistic Tumor Therapy [Corrigendum].
    Int J Nanomedicine; 2022; 17():3123-3124. PubMed ID: 35898437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erratum: Preparation of AS1411 Aptamer Modified Mn-MoS
    Int J Nanomedicine; 2023; 18():505-507. PubMed ID: 36733408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erratum: VCAM-1-Targeted Core/Shell Nanoparticles for Selective Adhesion and Delivery to Endothelial Cells with Lipopolysaccharide-Induced Inflammation under Shear Flow and Cellular Magnetic Resonance Imaging in vitro [Corrigendum].
    Int J Nanomedicine; 2022; 17():3401-3402. PubMed ID: 35942071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erratum: Emodin-Conjugated PEGylation of Fe
    Int J Nanomedicine; 2022; 17():711-712. PubMed ID: 35210770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erratum: Targeted Delivery of Doxorubicin Utilizing Chitosan Nanoparticles Surface Functionalized with Anti Her2 Trastuzumab [Corrigendum].
    Int J Nanomedicine; 2022; 17():5047-5048. PubMed ID: 36303805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erratum: Anti-Inflammatory Effects of Magnetically Targeted Mesenchymal Stem Cells on Laser-Induced Skin Injuries in Rats [Corrigendum].
    Int J Nanomedicine; 2020; 15():6735-6736. PubMed ID: 33061356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erratum: Targeted Polyethylene Glycol Gold Nanoparticles for the Treatment of Pancreatic Cancer: From Synthesis to Proof-of-Concept in vitro Studies [Corrigendum].
    Int J Nanomedicine; 2022; 17():3441-3442. PubMed ID: 35959284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erratum: Targeted Delivery Of Doxorubicin To HER2 Positive Tumor Models [Corrigendum].
    Int J Nanomedicine; 2019; 14():7919. PubMed ID: 31632008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erratum: Radiolabeling and Preliminary Evaluation of
    Int J Nanomedicine; 2022; 17():1479-1480. PubMed ID: 35378881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erratum: Increased Viability of Fibroblasts When Pretreated with Ceria Nanoparticles During Serum Deprivation [Corrigendum].
    Int J Nanomedicine; 2020; 15():3981. PubMed ID: 32606659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erratum: Effect of superparamagnetic nanoparticles coated with various electric charges on α-synuclein and β-amyloid proteins fibrillation process [Corrigendum].
    Int J Nanomedicine; 2019; 14():6733-6734. PubMed ID: 31507317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erratum: Size- and Shape-Dependent Clinical and Mycological Efficacy of Silver Nanoparticles on Dandruff [Corrigendum].
    Int J Nanomedicine; 2021; 16():7975-7976. PubMed ID: 34908834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erratum: Hyperthermia Mediated by Dextran-Coated La
    Int J Nanomedicine; 2022; 17():1481-1482. PubMed ID: 35378878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erratum: Solid Lipid Nanoparticles for Thermoresponsive Targeting: Evidence from Spectrophotometry, Electrochemical, and Cytotoxicity Studies [Corrigendum].
    Int J Nanomedicine; 2021; 16():5187. PubMed ID: 34354352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erratum: Solid Lipid Nanoparticles for Thermoresponsive Targeting: Evidence from Spectrophotometry, Electrochemical, and Cytotoxicity Studies [Corrigendum].
    Int J Nanomedicine; 2021; 16():6095-6096. PubMed ID: 34511907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.